SU11652（Cat No.:I036748）is a small molecule inhibitor that targets receptor tyrosine kinases (RTKs), particularly those involved in angiogenesis and tumor growth. It inhibits the activity of kinases like VEGFR (vascular endothelial growth factor receptor) and PDGFR (platelet-derived growth factor receptor), which are crucial for endothelial cell proliferation, migration, and new blood vessel formation. SU11652 shows promise in cancer therapy by disrupting tumor blood supply, thereby hindering tumor growth and metastasis. It is being studied as a potential treatment for various cancers, including those that exhibit resistance to conventional therapies.